Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus

被引：0
|
作者：
Buckley, Sophieanne [1 ]
Subramaniam, Yuvanaa [1 ,2 ]
Mallik, Ritwika [1 ,3 ]
Mukuba, Dorcas [1 ]
Casabar, Mahalia [4 ]
Ali, Omer [4 ]
Byrne, Connor [4 ]
Chowdhury, Tahseen A. [1 ]
机构：
[1] Royal London Hosp, Dept Diabet & Metab, 7th Floor,John Harrison House,Whitechapel, London E1 1BB, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Metab, London, England
[3] UCL, Ctr Obes Res, London, England
[4] Royal London Hosp, Dept Nephrol, London, England
来源：
DIABETIC MEDICINE | 2024年 / 41卷 / 08期
关键词：
D O I：
10.1111/dme.15383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Sodium-glucose co-transporter-2 inhibitors in Type 1 Diabetes: A Scoping Review
    Hropot, Tim
    Battelino, Tadej
    Dovc, Klemen
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 620 - 630
  • [22] Sodium-glucose co-transporter-2 inhibitors in the treatment of diabetes with heart failure COMMENT
    Liang, Bo
    Gu, Ning
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [23] Sodium-glucose co-transporter-2 inhibitors for type 1 diabetes: Not any more?
    Czupryniak, Leszek
    Danne, Thomas
    Szymanska-Garbacz, Elektra
    Zozulinska-Ziolkiewicz, Dorota
    Gumprecht, Janusz
    Klupa, Tomasz
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 764 - 765
  • [24] The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus
    Evans, Marc
    Morgan, Angharad R.
    Davies, Sarah
    Beba, Hannah
    Strain, William David
    AGE AND AGEING, 2022, 51 (10)
  • [25] Effect of sodium-glucose co-transporter-2 inhibitors on coronary blood flow in patients with type 2 diabetes mellitus
    Tastan, E.
    Soner, S.
    Comert, A. D.
    Altunbas, M.
    Tuzun, R.
    Ozturk, C.
    Akyuz, A.
    Isik, F.
    Cap, M.
    Bilge, O.
    Suleymanoglu, M.
    Oksul, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (16) : 7620 - 7628
  • [26] Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors in Thai adults with type 2 diabetes mellitus: a real-world study
    Sriphrapradang, Chutintorn
    Thewjitcharoen, Yotsapon
    Buranapin, Supawan
    Sawanyawisuth, Kittisak
    Yenseung, Nalin
    Ubonchareon, Wisawa
    Limpijankit, Laddawan
    Himathongkam, Thep
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1601 - 1610
  • [27] Sodium-glucose co-transporter-2 inhibitors: A paradigm shift in treatment for type 2 diabetes
    Matthews, David R.
    DIABETES OBESITY & METABOLISM, 2024, 26 : 3 - 4
  • [28] Sodium-glucose co-transporter-2 inhibitors and the risk of fractures in patients with type 2 diabetes
    Schmedt, Niklas
    Andersohn, Frank
    Walker, Jochen
    Garbe, Edeltraut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 454 - 454
  • [29] Sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients with type 2 diabetes mellitus: the road ahead
    Kramer, Caroline K.
    Zinman, Bernard
    EUROPEAN HEART JOURNAL, 2016, 37 (42) : 3201 - 3202
  • [30] The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
    Fadiran, Olusayo
    Nwabuo, Chike
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
12345